YEAR: 2008
21st Congress of the European College of Neuropsychopharmacology
30 August – 3 September 2008 , Barcelona
‘Innovation in the treatment of depression: a great leap forward’
Satellite symposium supported by an unrestricted educational grant from Servier at the 21st ECNP Congress
30 August 2008 , Barcelona
‘New horizons in Alzheimer’s disease: changing the course of the disease by targeting Aβ42’
Satellite symposium supported by an unrestricted educational grant from H. Lundbeck A/S and Myriad Pharmaceuticals Inc at the 21st ECNP Congress
30 August 2008 , Barcelona
International Congress of dual pathology Addictive Behaviors and other Mental Disorders
May, 29th-31st, Madrid, Spain
Satellite symposium at EFNS 2008
“Rasagiline use over the course of Parkinson’s disease”
Sponsored by H. Lundbeck A/S and Teva Pharmaceutical Industries Ltd
25th August 2008, Madrid
Satellite symposium at EFNS 2008
“New Horizons in Alzheimer’s disease diagnosis and treatment: Are we ready?”
Sponsored by Lundbeck A/S and Myriad
25th August 2008, Madrid
Satellite symposium at EFNS 2008
“Rasagiline use over the course of Parkinson’s disease”
Sponsored by H. Lundbeck A/S and Teva Pharmaceutical Industries Ltd
25th August 2008, Madrid
Satellite symposium at EFNS 2008
“Assessing the effects of Alzheimer’s disease treatment”
Sponsored by H. Lundbeck A/S and Merz Pharmaceuticals GmbH
24th August 2008, Madrid
Webcast by Koen Demyttenaere ‘Symptom Clusters in Mood: Does Pain Have a Role?’ based on a satellite symposium at the WPA. Sponsored by Eli Lilly and Company and Boehringer Ingelheim.
23 September, 2008, Prague, Czech Republic
Webcast by Michael Thase ‘Tactical Approaches to Achieve Optimal Remission’ based on a satellite symposium at the WPA. Sponsored by Eli Lilly and Company and Boehringer Ingelheim.
23 September, 2008, Prague, Czech Republic
Satellite symposium at the WPA
“Treating mood and pain disorders – from diagnosis to recovery?”
Sponsored by Eli Lilly and Boehringer Ingelheim
22 September, 2008, Prague, Czech Republic
1st UCB European ADHD Masterclass Meeting “Focus on ADHD”
22nd October 2008, Copenhagen
Satellite symposium at the WPA
“Recalibrationg Our Clinical Expectations in the Long-Term Treatment of Schizophrenia”
Sponsored by Eli Lilly and Company
21 September, 2008, Prague
Webcast ‘Schizophrenia – Long Term Challenges and Keeping Care Complete’ based on a satellite symposium at WPA Sponsored by Eli Lilly and Company
21 September, 2008, Prague, Czech Republic
Janssen Cilag EMEA stand-alone symposium
“Filling the gap between theory and practice in treating schizophrenia"
Day 2:Can we expect more from antipsychotic treatment of schizophrenia?
18th – 19th April 2008, Prague
Janssen Cilag EMEA stand-alone symposium
“Filling the gap between theory and practice in treating schizophrenia"
Day 2:Can we expect more from antipsychotic treatment of schizophrenia?
18th – 19th April 2008, Prague
6th UCB Masterclass
“Narcolepsy Moving Forward”
Barcelona, 19th April 2008
19 April 2008., Barcelona
Clinical Expert Forum 2008
Sponsored by Eli Lilly
19-20 September 2008, Prague, Czech Republic
Clinical Expert Forum 2008 Group 2
Sponsored by Eli Lilly
19-20 September 2008, Prague, Czech Republic
Janssen Cilag EMEA stand-alone symposium
“Filling the gap between theory and practice in treating schizophrenia"
Day 1: From clinical goals to real-life patient outcomes: how far have we progressed?
18th – 19th April 2008, Prague
Janssen Cilag EMEA stand-alone symposium
“Filling the gap between theory and practice in treating schizophrenia"
Day 1: From clinical goals to real-life patient outcomes: how far have we progressed?
18th – 19th April 2008, Prague
Diabetic Peripheral Neuropathic Pain
Expert forum meeting sponsored by Eli Lilly and Boehringer Ingelheim
Meeting room BRUCKNER: Group A
18th- 19th January 2008, Vienna
Diabetic Peripheral Neuropathic Pain
Expert forum meeting sponsored by Eli Lilly and Boehringer Ingelheim
Meeting room MAHLER: Group B
18th- 19th January 2008, Vienna
Webcast ‘The Importance of Early and Effective Treatment in Schizophrenia’ based on a satellite symposium at the CINP
Sponsored by Eli Lilly and Company
15 July, 2008, Munich, Germany
Satellite symposium ‘Long term management of bipolar disorder’ at the CINP
Sponsored by Janssen
15 July, 2008, Munich, Germany
ISAD 4th Biennal Conference
14-17 March 2008, Cape Town, South Africa
Satellite symposium ‘Changing Paradigms in the Long-Term Treatment of Schizophrenia’ at the CINP
Sponsored by Eli Lilly and Company
13 July, 2008, Munich, Germany
Organon satellite symposium
« New perspectives in antipsychotic therapy »
XXVI Collegium Internationale Neuro-Psychopharmacologicum (CINP)
13 July, 2008, Munich, Germany
Lundbeck International Expert Meeting –
Present Perspective on altering the course of schizophrenia
12th June 2008, Warsaw, Poland
Astra Zeneca satellite Symposium
16th European Congress of Psychiatry 2008
Nice, France, 5-9 Avril 2008
8 April 2008., Nice
Masterclass
“Refractory Epilepsies”
7-8 November 2008, Florence
Stand-alone
'The psychosocial burden of epilepsy: ameliorating the impact',
6th-8th April 2008, Oxford
Converging Perspectives on Pain Management
6–8 November 2008, Hilton Vienna, Vienna, Austria
Converging Perspectives on Pain Management
An International Pain Conference supported by
Eli Lilly and Company & Boehringer Ingelheim
6–8 November 2008, Vienna, Austria
Converging Perspectives on Pain Management
An International Pain Conference supported by
Eli Lilly and Company & Boehringer Ingelheim
6–8 November 2008, Vienna, Austria
Lundbeck stand-alone symposium
“Rasagiline – the foundation for Parkinson’s disease management”
Budapest, 6th April 2008,
9th International Psychiatry Forum
Sponsored by Sanofi Aventis
6-7 June 2008, Prague
Stand-alone symposium « Alzheimer’s disease – one century later » sponsored by H. Lundbeck A/S
Budapest, 5th April 2008,
International Masters in Affective Neuroscience
Summer course on Anxiety Disorders
5-10 July 2008 , Florence
Faculty Update Meeting
Webcast “From molecule to management: the scope of schizophrenia treatment”
Educational financial support provided by Janssen-Cilag
5 December 2008, Budapest
Faculty Update Meeting
“From molecule to management: the scope of schizophrenia treatment”
Educational financial support provided by Janssen-Cilag
5 December 2008, Budapest
‘Achieving complete remission in depression: clinical reality or therapeutic challenge’
Satellite symposium supported by an unrestricted educational grant from Servier at the 21st ECNP Congress
3 September 2008 , Barcelona
7th International Narcolepsy Masterclass
“Narcolepsy: are we meeting expectations”
October 3rd and 4th 2008, Brussels, Belgium
‘First steps in schizophrenia management: the importance of early intervention
Satellite symposium supported by Bristol-Myers Squibb and Otsuka Pharmaceutical Europe Ltd. at the 21st ECNP Congress
September 2, 2008, Barcelona
Janssen Cilag EMEA
Satellite symposium
“New views on ADHD: looking at broader outcomes”
IACAPAP Congress
1st May 2008, Istanbul
Challenges in the management of behavioural problems in Alzheimer’s disease’
Satellite symposium supported by an unrestricted educational grant from H. Lundbeck A/S and Merz Pharmaceuticals GmbH at the 21st ECNP Congress
September 1st, 2008, Barcelona
‘Mania matters: Focus on treatment, co-morbidity, course and outcome’
Satellite symposium supported by an unrestricted educational grant from Organon at the 3rd Biennal Conference of the International Society of Bipolar Disorders
30 January, 2008 , Agra, India
Managing patients posing a danger to themselves or others
Neuropsychology symposium organised by the European Institute of Healthcare
26th January 2008 , Brussels
Changing Paradigms in Major Depressive Disorders
An International Conference in Psychiatry supported by
Eli Lilly and Company & Boehringer Ingelheim
21 to 23 February 2008, Copenhagen, Denmark
Overcoming everyday challenges in Alzheimer’s disease
Expert meeting sponsored by H. Lundbeck A/S
8th February 2008, Munich
Masterclass on “Seizures and Epilepsy in the Elderly”
28th -29th March 2008, Mainz
MDD Expert forum meeting Group A
sponsored by Eli Lilly
14-15 March 2008, Prague, Czech Republic
MDD Expert forum meeting Group B
sponsored by Eli Lilly
14-15 March 2008, Prague, Czech Republic
Regional Medical Conference
‘Response to Remission in the Treatment of Major Depression’
Sponsored by Eli Lilly
26th April 2008, Berlin, Germany
Regional Medical Conference
Zyprexa RNC ‘Improving Long-Term Outcome in schizophrenia and Bipolar Disorder’
Sponsored by Eli Lilly
25th April 2008, Berlin, Germany
Stand-alone symposium
« Optimizing the management of patients with schizophrenia »
sponsored by H. Lundbeck A/S
Budapest, 5th April 2008,
Janssen-Cilag Second Faculty Update Meeting
“Drugs don’t work in patients who don’t take them: how to support long-term treatment in schizophrenia”
13 June 2008 , Brussels
Promoters and barriers to adherence and overall health status in patients with serious mental illness
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from Pfizer, Inc.
August 30, 2008, Barcelona
Generalised anxiety disorder and fibromyalgia. Is there an association? Weighing the range of therapeutic options
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from Pfizer Inc.
August 31, 2008, Barcelona
Long-term management of bipolar disorder
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from Janssen-Cilag
August 31st, 2008, Barcelona
Improving antipsychotic therapy for better patient outcomes
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from Janssen-Cilag
August 30th, 2008, Barcelona
Progress in depression: new developments in short-term management and patient care
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from AstraZeneca
30-Aug-08, Barcelona
Predicting Response and Remission in Schizophrenia
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from Eli Lilly and Company
30-Aug-08, Barcelona
Long-Term Treatment of Schizophrenia:
New Perspectives
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from Eli Lilly and Company
31-Aug-08, Barcelona
New Vistas in Treating Mood and Pain Disorders
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from Eli Lilly and Company and Boehringer Ingelheim
30 August, 2008 , Barcelona
Managing patients with bipolar mania: are our needs being met ?
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co.
August 30, 2008, Barcelona
Innovation in the treatment of depression: a great leap forward
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from Servier
August 30, 2008, Barcelona
New horizons in Alzheimers disease: changing the course of the disease by targeting ABETA42
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from H. Lundbeck A/S and Myriad Pharmaceuticals Inc
30th August, 2008, Barcelona
Has melatonin a role in the treatment of insomnia?
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from H/Lundbeck A/S
August 30th, 2008, Barcelona
Mood disorders still challenges to face
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from H. Lundbeck A/S
August 31st, 2008, Barcelona
21st Congress of the European College of Neuropsychopharmacology
30 August 3 September 2008, Barcelona
Approaches to improve outcomes in CNS clinical trials
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from United BioSource Corporation
September 2nd, 2008, Barcelona
Towards remission: balancing efficacy and tolerability
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an
educational grant from GlaxoSmithKline
2nd September 2008, Barcelona
New advances for patients with bipolar disorder: a focus on the latest clinical trial data
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an
educational grant from AstraZeneca
02-Sep-08, Barcelona
Bipolar Disorder: From Randomised Controlled Trials to Observational Studies—Lessons for Clinical Practice
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from Eli Lilly and Company
03-Sep-08, Barcelona
Long-term management of schizophrenia from receptors to large-scale prospective studies
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an
educational grant from H. Lundbeck A/S
3rd September 2008, Barcelona
First steps in schizophrenia management: the importance of early intervention
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant by Bristol-Myers Squibb and Otsuka Pharmaceutical Europe Ltd.
September 2, 2008, Barcelona
Evolving priorities in antipsychotic treatment
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from Schering-Plough
September 1st, 2008, Barcelona
Addressing the unmet needs of our depressed patients
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from Wyeth
September 1st, 2008, Barcelona
Achieving complete remission in depression: clinical reality or therapeutic challenge
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from Servier
September 3 2008, Barcelona
Challenges in the management of behavioural problems in Alzheimers disease
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from H. Lundbeck A/S and Merz Pharmaceuticals GmbH
September 1st, 2008, Barcelona
Advancing insomnia therapy: circuitry, pharmacology, and comorbidity
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from GlaxoSmithKline
September 1st, 2008, Barcelona
Why psychiatrists should not ignore pain in their patients - focus on fibromyalgia
Satellite symposium on the occasion of the
21st Congress of European College of Neuropsychopharmacology supported by an educational grant from Pierre Fabre Médicaments
03-Sep-08, Barcelona